Client News

APEIRON Biologics closes oversubscribed financing round of EUR 17.5 million for the development of APN01 against COVID-19

CENTOGENE AG: Resumption of air traffic at Rostock-Laage airport: CENTOGENE AG tests airport employees for the SARS-CoV-2-virus

France Biotech: HealthTech For Care and EIT Health Announce Partnership to Support the Acceleration of European HealthTech Companies

faCellitate announces the launch of its first product BIOFLOAT™ for improved 3D cell culture

Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase II Study

Sterna biologicals secures EUR 12.0 million in private placement

Abivax announces German regulatory approval of ABX464 Covid-19 Phase 2b/3 COVID-19 clinical trial

InflaRx Reports Q1 2020 Financial & Operating Results

Simple and rapid SARS-CoV-2 diagnostic test project with 4basebio’s contribution receives funding from “la Caixa” Banking Foundation

Rentschler Biopharma licenses Horizon Discovery’s CHOSOURCE platform to complement cell line development offering for difficult-to-express proteins